Back to Search Start Over

Impact of a Home Telehealth Program After a Hospitalized COPD Exacerbation: A Propensity Score Analysis.

Authors :
Marcos PJ
Represas Represas C
Ramos C
Cimadevila Álvarez B
Fernández Villar A
Fraga Liste A
Fernández Nocelo S
Quiles Del Río J
Zamarrón Sanz C
Golpe R
Abal Arca J
Calvo Álvarez U
Pértega S
García Comesaña J
Source :
Archivos de bronconeumologia [Arch Bronconeumol] 2022 Jun; Vol. 58 (6), pp. 474-481. Date of Electronic Publication: 2020 Jun 27.
Publication Year :
2022

Abstract

Introduction: Currently there is lack of data regarding the impact of a home telehealth program on readmissions and mortality rate after a COPD exacerbation-related hospitalization.<br />Objective: To demonstrate if a tele-monitoring system after a COPD exacerbation admission could have a favorable effect in 1-year readmissions and mortality in a real-world setting.<br />Methods: This is an observational study where we compared an intervention group of COPD patients treated after hospitalization that conveyed a telehealth program with a followance period of 1 year with a control group of patients evaluated during one year before the intervention began. A propensity-score analyses was developed to control for confounders. The main clinical outcome was 1-year all-cause mortality or COPD-related readmission.<br />Results: The analysis comprised 351 telemonitoring patients and 495 patients in the control group. The intervention resulted in less mortality or readmission after 12 months (35.2% vs. 45.2%; hazard ratio [HR] 0.71 [95% CI=0.56-0.91]; p=0.007). This benefit was maintained after the propensity score analysis (HR=0.66 [95% CI=0.51-0.84]). This benefit, which was seen from the first month of the study and during its whole duration, is maintained when mortality (HR=0.54; 95% CI=[0.36-0.82]) or readmission (subdistribution hazard ratio [SHR] 0.66; 95% CI=[0.50-0.86]) are analyzed separately.<br />Conclusion: Telemonitoring after a severe COPD exacerbation is associated with less mortality or readmissions at 12 months in a real world clinical setting.<br /> (Copyright © 2020 SEPAR. Published by Elsevier España, S.L.U. All rights reserved.)

Details

Language :
English; Spanish; Castilian
ISSN :
1579-2129
Volume :
58
Issue :
6
Database :
MEDLINE
Journal :
Archivos de bronconeumologia
Publication Type :
Academic Journal
Accession number :
32600850
Full Text :
https://doi.org/10.1016/j.arbres.2020.05.030